Helius Medical Technologies Stock Filter Stocks by Fundamentals
HSDT Stock | USD 4.82 0.16 3.21% |
Helius Medical Technologies fundamentals help investors to digest information that contributes to Helius Medical's financial success or failures. It also enables traders to predict the movement of Helius Stock. The fundamental analysis module provides a way to measure Helius Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Helius Medical stock.
Helius | Number of Employees |
Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
All Next | Launch Module |
Helius Fundamentals
Return On Equity | -1.69 | ||||
Return On Asset | -0.61 | ||||
Operating Margin | (16.76) % | ||||
Current Valuation | (706.27 K) | ||||
Shares Outstanding | 887.29 K | ||||
Shares Owned By Insiders | 0.85 % | ||||
Shares Owned By Institutions | 11.58 % | ||||
Number Of Shares Shorted | 72.19 K | ||||
Price To Earning | (13.85) X | ||||
Price To Book | 2.22 X | ||||
Price To Sales | 8.50 X | ||||
Revenue | 644 K | ||||
Gross Profit | 324 K | ||||
EBITDA | (12.11 M) | ||||
Net Income | (8.85 M) | ||||
Cash And Equivalents | 3.27 M | ||||
Cash Per Share | 0.12 X | ||||
Total Debt | 57 K | ||||
Debt To Equity | 0.03 % | ||||
Current Ratio | 2.85 X | ||||
Book Value Per Share | 3.29 X | ||||
Cash Flow From Operations | (10.42 M) | ||||
Short Ratio | 0.18 X | ||||
Earnings Per Share | (14.56) X | ||||
Target Price | 15.47 | ||||
Number Of Employees | 22 | ||||
Beta | 1.55 | ||||
Market Capitalization | 4.42 M | ||||
Total Asset | 7.69 M | ||||
Retained Earnings | (159.96 M) | ||||
Working Capital | 5.56 M | ||||
Current Asset | 6.8 M | ||||
Current Liabilities | 4.46 M | ||||
Net Asset | 7.69 M |
About Helius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Helius Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Helius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Helius Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Helius Medical Piotroski F Score and Helius Medical Altman Z Score analysis. Note that the Helius Medical Techn information on this page should be used as a complementary analysis to other Helius Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Helius Stock analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Helius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Helius Medical. If investors know Helius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Helius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.56) | Revenue Per Share 1.059 | Quarterly Revenue Growth (0.53) | Return On Assets (0.61) | Return On Equity (1.69) |
The market value of Helius Medical Techn is measured differently than its book value, which is the value of Helius that is recorded on the company's balance sheet. Investors also form their own opinion of Helius Medical's value that differs from its market value or its book value, called intrinsic value, which is Helius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Helius Medical's market value can be influenced by many factors that don't directly affect Helius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Helius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Helius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Helius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.